ACON Investments Acquires BioMatrix Specialty Pharmacy

Monday, November 28, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, Nov. 28, 2016 /PRNewswire/ -- ACON Investments, L.L.C. and its affiliates ("ACON") announced it has recently

completed the purchase of BioMatrix Specialty Pharmacy, L.L.C. ("BioMatrix" or the "Company"), a specialty pharmacy platform company with a focus on both infused and oral specialty drugs.

As part of this transaction, ACON partnered

with Tracy Finn and Patrick Keefe, two former senior executives of Omnicare, Inc. ACON is also joined by Triton Pacific Capital Partners, LLC ("Triton Pacific"), an experienced private equity healthcare services investor. The Company will continue to be led by CEO Bruce Greenberg and other members of the existing senior management team, together with Tracy Finn who will serve as Executive Chairman.

"We are excited to partner with the management of BioMatrix, Tracy, Pat, and Triton Pacific to build a leading independent specialty pharmacy organization," said Daniel Jinich, Managing Partner of ACON. "BioMatrix has earned the trust of patients, physicians, payers and pharmaceutical manufacturers due to its exceptional service, clinical capabilities and innovative technology tools. We see significant opportunity to leverage the existing capabilities of BioMatrix to diversify into new therapeutic categories while broadening the network of referral sources," added Jinich.

"The entire management team is excited about our partnership with ACON, Triton Pacific, Tracy and Pat," said Bruce Greenberg. "We are grateful that our new investors share our dedication to patient service and clinical excellence. We're extremely proud of the company we've built together and I am excited to build on this momentum with our new investors."

"I am pleased to partner with this excellent management team and look forward to working together to continue to deliver exceptional service to our patients and all of our stakeholders," said Tracy Finn.

"In addition to growing the business organically, BioMatrix is capitalized to pursue strategic acquisitions in existing and new therapeutic categories. We look forward to working with our partners at ACON, our operating executives, Tracy and Pat, and the excellent management team at BioMatrix to accelerate these growth initiatives," said Joe Davis, Managing Partner at Triton Pacific.

Debt financing for the acquisition was provided by Capital One through syndicated credit facilities. Hogan Lovells US LLP and DLA Piper LLP US acted as legal advisers to ACON and Dickson Wright PLLC acted as legal adviser to the sellers. Robert W. Baird & Co. acted as exclusive financial adviser to BioMatrix in the transaction.

Terms of the transaction were not disclosed.

About BioMatrixHeadquartered in Weston, Florida, BioMatrix was formed in 2015 through the merger of Matrix Health Group and BiologicTx, two specialty pharmacy companies with a common emphasis on a high-touch, clinically sophisticated and patient-centric care management model. With a network of seven pharmacies, the Company is a leading provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix has relationships with leading physicians, medical facilities and payors; and its Digital Health platform, provides innovative solutions for care givers, patients, payors and other stakeholders. For more information on the company, please visit

About ACON InvestmentsACON Investments, L.L.C. is a Washington, DC-based international private equity investment firm that manages private equity funds and special purpose partnerships that make investments in the United States and Latin America. Founded in 1996, ACON has responsibility for managing approximately $4.8 billion of capital. ACON has professionals in Washington, DC, Los Angeles, Mexico City, São Paulo and Bogotá. For more information, visit

About Triton PacificTriton Pacific Capital Partners, LLC, founded in 2001, is a private equity firm that invests in middle-market companies in high growth or rapidly changing industries. Headquartered in Los Angeles, California, Triton Pacific currently manages four private equity funds and is the sponsor of Triton Pacific Investment Corporation, a non-traded public Business Development Company. For more information, visit

CONTACTS: Daniel JinichACON Investments, L.L.C.(202) 454-1108

John Morgan BarrACON Investments, L.L.C.(310) 788-5713

Joe DavisTriton Pacific Capital Partners, LLC (949) 542-8800

To view the original version on PR Newswire, visit:

SOURCE ACON Investments, L.L.C.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store